Fri, 16 Mar 2018 14:27:33 GMT
Platinum Equity offers $2.1B for JNJ's diabetes unit
Johnson & Johnson stated on Friday that the private investment company Platinum Equity had offered around $2.1B for its diabetes unit LifeScan, known for producing blood glucose monitoring products.